Based on a panel of HCC cell lines, the present investigation dealt with the question of how AKT/mTOR and the CDK-Cyclins modify integrin expression and how integrins contribute to the altered AKT/mTOR and CDK-Cyclin signaling. This evidence concerns the gene AKT1 and hepatocellular carcinoma.